Article

Recovery from acute spinal cord injury (SCI) is characterized by extensive
heterogeneity, resulting in uncertain prognosis. Reliable prediction of recovery
in the acute phase benefits patients and their families directly, as well as
improves the likelihood of detecting efficacy in clinical trials. This issue of
heterogeneity is not unique to SCI. In fields such as traumatic brain injury,
Parkinson's disease, and amyotrophic lateral sclerosis,
one approach to
understand variability in recovery has been to make clinical trial data widely
available to the greater research community. We contend that the SCI community should adopt a similar approach in providing open access clinical trial data.

Langue : ANGLAIS